MEOX2 and cancer: In summary, our results provide evidence for a novel transcriptional-epigenetic MEOX2-GLI1 axis that is involved in cellular viability, cancer drug resistance, cellular proliferation and migration capacity, and overall clinical survival and therapy prognosis in lung cancer.